307 related articles for article (PubMed ID: 23350642)
1. Trihydroxamate siderophore-fluoroquinolone conjugates are selective sideromycin antibiotics that target Staphylococcus aureus.
Wencewicz TA; Long TE; Möllmann U; Miller MJ
Bioconjug Chem; 2013 Mar; 24(3):473-86. PubMed ID: 23350642
[TBL] [Abstract][Full Text] [Related]
2. Sideromycins: tools and antibiotics.
Braun V; Pramanik A; Gwinner T; Köberle M; Bohn E
Biometals; 2009 Feb; 22(1):3-13. PubMed ID: 19130258
[TBL] [Abstract][Full Text] [Related]
3. Synthetic sideromycins (skepticism and optimism): selective generation of either broad or narrow spectrum Gram-negative antibiotics.
Lin YM; Ghosh M; Miller PA; Möllmann U; Miller MJ
Biometals; 2019 Jun; 32(3):425-451. PubMed ID: 30919118
[TBL] [Abstract][Full Text] [Related]
4. Immobilized FhuD2 Siderophore-Binding Protein Enables Purification of Salmycin Sideromycins from Streptomyces violaceus DSM 8286.
Rivera GSM; Beamish CR; Wencewicz TA
ACS Infect Dis; 2018 May; 4(5):845-859. PubMed ID: 29460625
[TBL] [Abstract][Full Text] [Related]
5. Design and Syntheses of New Antibiotics Inspired by Nature's Quest for Iron in an Oxidative Climate.
Miller MJ; Liu R
Acc Chem Res; 2021 Apr; 54(7):1646-1661. PubMed ID: 33684288
[TBL] [Abstract][Full Text] [Related]
6. Hydroxamate siderophores: Natural occurrence, chemical synthesis, iron binding affinity and use as Trojan horses against pathogens.
Al Shaer D; Al Musaimi O; de la Torre BG; Albericio F
Eur J Med Chem; 2020 Dec; 208():112791. PubMed ID: 32947228
[TBL] [Abstract][Full Text] [Related]
7. Species selectivity of new siderophore-drug conjugates that use specific iron uptake for entry into bacteria.
Diarra MS; Lavoie MC; Jacques M; Darwish I; Dolence EK; Dolence JA; Ghosh A; Ghosh M; Miller MJ; Malouin F
Antimicrob Agents Chemother; 1996 Nov; 40(11):2610-7. PubMed ID: 8913474
[TBL] [Abstract][Full Text] [Related]
8. Biscatecholate-monohydroxamate mixed ligand siderophore-carbacephalosporin conjugates are selective sideromycin antibiotics that target Acinetobacter baumannii.
Wencewicz TA; Miller MJ
J Med Chem; 2013 May; 56(10):4044-52. PubMed ID: 23614627
[TBL] [Abstract][Full Text] [Related]
9. Structural Basis for Xenosiderophore Utilization by the Human Pathogen Staphylococcus aureus.
Endicott NP; Lee E; Wencewicz TA
ACS Infect Dis; 2017 Jul; 3(7):542-553. PubMed ID: 28505405
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and in vitro antibacterial activity of spermidine-based mixed catechol- and hydroxamate-containing siderophore--vancomycin conjugates.
Ghosh M; Miller MJ
Bioorg Med Chem; 1996 Jan; 4(1):43-8. PubMed ID: 8689237
[TBL] [Abstract][Full Text] [Related]
11. Is drug release necessary for antimicrobial activity of siderophore-drug conjugates? Syntheses and biological studies of the naturally occurring salmycin "Trojan Horse" antibiotics and synthetic desferridanoxamine-antibiotic conjugates.
Wencewicz TA; Möllmann U; Long TE; Miller MJ
Biometals; 2009 Aug; 22(4):633-48. PubMed ID: 19221879
[TBL] [Abstract][Full Text] [Related]
12. Desketoneoenactin-siderophore conjugates for Candida: evidence of iron transport-dependent species selectivity.
Bernier G; Girijavallabhan V; Murray A; Niyaz N; Ding P; Miller MJ; Malouin F
Antimicrob Agents Chemother; 2005 Jan; 49(1):241-8. PubMed ID: 15616301
[TBL] [Abstract][Full Text] [Related]
13. Exploring the Antibacterial Activity and Cellular Fates of Enterobactin-Drug Conjugates That Target Gram-Negative Bacterial Pathogens.
Guo C; Nolan EM
Acc Chem Res; 2024 Apr; 57(7):1046-1056. PubMed ID: 38483177
[TBL] [Abstract][Full Text] [Related]
14. Selective growth promotion and growth inhibition of gram-negative and gram-positive bacteria by synthetic siderophore-beta-lactam conjugates.
Möllmann U; Ghosh A; Dolence EK; Dolence JA; Ghosh M; Miller MJ; Reissbrodt R
Biometals; 1998 Jan; 11(1):1-12. PubMed ID: 9450313
[TBL] [Abstract][Full Text] [Related]
15. Siderophore-Antibiotic Conjugate Design: New Drugs for Bad Bugs?
Negash KH; Norris JKS; Hodgkinson JT
Molecules; 2019 Sep; 24(18):. PubMed ID: 31514464
[TBL] [Abstract][Full Text] [Related]
16. Staphyloferrin A as siderophore-component in fluoroquinolone-based Trojan horse antibiotics.
Milner SJ; Seve A; Snelling AM; Thomas GH; Kerr KG; Routledge A; Duhme-Klair AK
Org Biomol Chem; 2013 Jun; 11(21):3461-8. PubMed ID: 23575952
[TBL] [Abstract][Full Text] [Related]
17. Iron transport-mediated drug delivery using mixed-ligand siderophore-beta-lactam conjugates.
Ghosh A; Ghosh M; Niu C; Malouin F; Moellmann U; Miller MJ
Chem Biol; 1996 Dec; 3(12):1011-9. PubMed ID: 9000006
[TBL] [Abstract][Full Text] [Related]
18. New synthetic siderophores and their beta-lactam conjugates based on diamino acids and dipeptides.
Wittmann S; Schnabelrauch M; Scherlitz-Hofmann I; Möllmann U; Ankel-Fuchs D; Heinisch L
Bioorg Med Chem; 2002 Jun; 10(6):1659-70. PubMed ID: 11937324
[TBL] [Abstract][Full Text] [Related]
19. Vectorization via Siderophores Increases Antibacterial Activity of K(RW)
Olshvang E; Fritsch S; Scholtyssek OC; Schalk IJ; Metzler-Nolte N
Chemistry; 2023 Sep; 29(50):e202300364. PubMed ID: 37541431
[TBL] [Abstract][Full Text] [Related]
20. Siderophore-drug complexes: potential medicinal applications of the 'Trojan horse' strategy.
Górska A; Sloderbach A; Marszałł MP
Trends Pharmacol Sci; 2014 Sep; 35(9):442-9. PubMed ID: 25108321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
